CA23859-4 - 0x000000000000341B

Study Number: CA23859
Group Number: 4
Study Requirement: Cystic Fibrosis
Stipend: up to £ 1,487

Study Criteria:

  • Age: 18 - 0
  • BMI: 16 - 29.9
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat Cystic Fibrosis.
  • Route of Administration: Oral
  • Blood Draws: 17

Study Schedule:

  • Schedule Type: Return Only
  • Study Length: 7 Returns & 3 Phone Calls

Screening Dates:

Event Day Event Date Site
No search results

Doctor Exam Dates:

Event Day Event Date Site
No search results

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Return Thursday Aug 9 2018 7:15AM Thursday Aug 9 2018 9:30AM 1 Belfast
Return Friday Aug 10 2018 6:30AM Friday Aug 10 2018 8:30PM 1 Belfast
Return Saturday Aug 11 2018 7:15AM Saturday Aug 11 2018 9:00AM 1 Belfast
Phone participant* Wednesday Aug 15 2018 11:00AM 1 Belfast
Return Thursday Aug 16 2018 6:45AM Thursday Aug 16 2018 10:45AM 1 Belfast
Phone participant* Wednesday Aug 22 2018 11:00AM 1 Belfast
Return Thursday Aug 23 2018 6:45AM Thursday Aug 23 2018 8:30PM 1 Belfast
Return Friday Aug 24 2018 7:30AM Friday Aug 24 2018 8:30AM 1 Belfast
Phone participant* Wednesday Aug 29 2018 9:00PM 1 Belfast
Return Thursday Aug 30 2018 7:00AM Thursday Aug 30 2018 10:00AM 1 Belfast